Search clinical trials for: Histologically confirmed NASH
Total 11037 results
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Johannes Gutenberg University MainzUniversity of JenaCompletedNon-alcoholic Fatty Liver Disease | Fatty Liver, NonalcoholicGermany
-
Boehringer IngelheimRecruitingObesity | Non-Alcoholic SteatoHepatitis (NASH)United States
-
Zhejiang Cancer HospitalNot yet recruitingHistologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis
-
Boston PharmaceuticalsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
89bio, Inc.ProSciento, Inc.Completed
-
Latin American Cooperative Oncology GroupActive, not recruitingNeuroendocrine Tumors | Carcinoma;EndocrineBrazil, Peru
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Sagimet Biosciences Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States, Canada, Puerto Rico, Poland
-
Technical University of MunichCompletedAdenocarcinoma of the Esophagogastric JunctionGermany
-
Institut Claudius RegaudAstraZenecaActive, not recruitingDiffuse Large B-cell LymphomaFrance
-
Ology BioservicesCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingCarcinoma | CancerUnited States
-
Centre Hospitalier Régional d'OrléansCompletedHuman Papilloma Virus Infection | Squamous Intraepithelial Lesions of the Cervix | Cervix LesionFrance
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
Hoffmann-La RocheCompletedRenal Cell CarcinomaKorea, Republic of, United States, France, Italy, United Kingdom, Canada, Australia, Brazil, Denmark, Spain, Turkey, Japan, Czechia, Singapore, Thailand, Taiwan, Russian Federation, Germany, Bosnia and Herzegovina, Poland, Mexico
-
Galderma R&DCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteEisai Inc.CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)TerminatedPancreatic Neoplasms | Pancreatic Cancer | Metastatic Pancreatic Cancer | Histologically or Cytologically Confirmed Pancreatic Cancer | Unresectable or Borderline Resectable Pancreatic CancerUnited States
-
AbbVieTerminatedEndometriosis | Dysmenorrhea | Chronic Pelvic PainUnited States
-
National Institute of Allergy and Infectious Diseases...Lederle Laboratories; Hoechst Marion RousselCompletedHIV Infections | TuberculosisUnited States, Puerto Rico
-
University of OxfordPfizer; Belfast Health and Social Care Trust; Queen's University, Belfast; Saint... and other collaboratorsCompletedColorectal Cancer | Solid TumorUnited Kingdom
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
Galecto Biotech ABCovanceWithdrawn
-
Novartis PharmaceuticalsCompletedSolid TumorsGermany, United States, Netherlands, Spain, Canada, Hong Kong, Italy, Singapore, Australia, Israel, Korea, Republic of, Taiwan, France, Norway, Thailand
-
Novartis PharmaceuticalsTerminatedHistologically-proven and Radiologically-confirmed Solid TumorsItaly, New Zealand
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
OncoMed Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedNonsquamous Nonsmall Cell Neoplasm of LungSpain, United States, Australia, Italy, Belgium
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedPancreatic CancerAustralia, New Zealand, Spain
-
OncoMed Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
OncoMed Pharmaceuticals, Inc.Completed
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedNon Small Cell Lung CancerAustralia, New Zealand, Spain
-
OncoMed Pharmaceuticals, Inc.Completed
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedColorectal CancerAustralia, New Zealand
-
OncoMed Pharmaceuticals, Inc.BayerCompleted
-
Medstar Health Research InstitutePfizerCompletedPapillary Thyroid Cancer | Differentiated Thyroid Cancer | Follicular Thyroid CancerUnited States
-
Instituto Nacional de Cancerologia de MexicoCompletedPhase II Clinical Trial | Ninety-six Histologically Confirmed NSCLC Patients With BM | Randomized 1:1 to Received TN Plus WBR or Only WBR | ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRIMexico
-
Centro Nacional de Investigaciones Oncologicas...M.D. Anderson Cancer Center; Hospital Universitari de Bellvitge; Hospital Universitario...Terminated
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Karolinska University HospitalUllevaal University Hospital; Oslo University Hospital; Sahlgrenska University... and other collaboratorsCompletedCarcinoma, Squamous Cell | Adenocarcinoma of the Esophagus and Gastric CardiaSweden
-
National Cancer Institute (NCI)CompletedHistologically or Cytologically Confirmed Pancreatic Ca | Unresectable or Borderline Resectable Pancreatic CaUnited States
-
Memorial Sloan Kettering Cancer CenterWithdrawnHistologically-confirmed MalignanciesUnited States
-
Centre Leon BerardMinistry of Health, FranceTerminatedHistologically Confirmed Medulloblastoma | Activation of the Sonic Hedgehog (SHH) PathwayFrance, Italy, Switzerland, United Kingdom
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
University Health Network, TorontoCompletedPreviously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV MelanomaCanada